Open AccessROLE OF DIABETES AND NONALCOHOLIC FATTY LIVER DISEASE FOR HCC DEVELOPMENT
Author(s) -
LEVAN BENASHVILI,
TAMAR TURMANIDZE,
EVGENI ASATIANI
Publication year - 2022
Publication title -
ek'sperimentuli da klinikuri medic'ina
Language(s) - English
Resource type - Journals
ISSN - 1512-0392
DOI - 10.52340/jecm.2022.717
Subject(s) - hepatocellular carcinoma , medicine , cirrhosis , nonalcoholic fatty liver disease , diabetes mellitus , fatty liver , etiology , malignancy , chronic liver disease , liver cancer , liver disease , disease , risk factor , incidence (geometry) , gastroenterology , cancer , obesity , endocrinology , physics , optics
Hepatocellular carcinoma (HCC) is the most common primary liver malignancy and is a leading cause of cancer-related death worldwide. Despite advances in prevention techniques, screening, and new technologies in both diagnosis and treatment, incidence and mortality continue to rise. Cirrhosis remains the most important risk factor for the development of HCC regardless of etiology. Chronic medical conditions such as diabetes mellitus and obesity increase the risk of HCC. Diabetes mellitus directly affects the liver because of the essential role the liver plays in glucose metabolism. It can lead to chronic hepatitis, fatty liver, liver failure, and cirrhosis